Searchable abstracts of presentations at key conferences in endocrinology

ea0021pl7biog | Society for Endocrinology Medal Lecture | SFEBES2009

Society for Endocrinology Medal Lecture

Arlt W

W Arlt, School of Clinical and Experimental Medicine, Centre for Endocrinology, Diabetes and Metabolism, University of Birmingham, Birmingham, UK AbstractProf. Wiebke Arlt received her undergraduate medical training at the University of Cologne in Germany. She obtained her MD degree in 1993 with distinction and trained in General Medicine and Endocrinology and Diabetes at the University Hospital Würzburg under th...

ea0019s4biog | Society for Endocrinology European Medal Lecture | SFEBES2009

Society for Endocrinology European Medal Lecture

Wiersinga W

W Wiersinga, University of Amsterdam, Amsterdam, The Netherlands AbstractWilmar M Wiersinga obtained his MD in Amsterdam in 1969 and his Board Certification in Internal Medicine in 1976. He obtained his PhD cum laude in 1979 at the University of Amsterdam on the thesis ‘The peripheral conversion of T4 into T3 and reverse T3’. Thereafter he spent two years as a research fellow at the UCLA with professors David...

ea0034pl2biog | SfE Dale Medal Lecture 2014 | SFEBES2014

Society for Endocrinology Dale Medal Lecture 2014

O'Malley Bert W

Bert W O’MalleyBert W O’Malley, MD is the Tom Thompson Distinguished Service Professor of Molecular and Cellular Biology at Baylor College of Medicine. A native of Pittsburgh, he has a bachelor’s degree from the University of Pittsburgh (1959) and an MD from their School of Medicine (1963). He completed his residency at Duke University and spent four years at the National Institute of Health followed by four years serving as the Luscious B...

ea0021pl6biog | Clinical Endocrinology Trust Visiting Professor Lecture | SFEBES2009

Clinical Endocrinology Trust Visiting Professor Lecture

Young W F

W F Young Jr, Mayo Clinic, Rochester, Minnesota, USA AbstractProf. William Young is Professor of Medicine at the Mayo Clinic College of Medicine and Vice-Chair of the Division of Endocrinology, Diabetes, Metabolism, and Nutrition. He received his MD degree from Michigan State University. Prof. Young trained in endocrinology and metabolism at Mayo Clinic, Rochester, Minnesota. He has been a member of the staff at Mayo ...

ea0041ep833 | Obesity | ECE2016

Lipodystrophia ın a pregnant women wıth unregulated glycemıa

Doğan Bercem Aycicek , Arıkan Tuğba , Donmez Emre

Introduction: Many endocrinopathies such as acromegaly, Cushing’s syndrome (CS), pheomochromocytom and lipodystrophia can be associated with insülin resistance and unregulated diabetes mellitus (DM).Case report: A 37 –year- and 2 months pregnant women admitted to our out patient clinic for regulation of hyperglycemia. On physical examination; Blood Pressure: 140/95 mmHg, Body Mass Index: 31 kg/m2, central obesity, acanthosis nig...

ea0029p53 | Adrenal cortex | ICEECE2012

Relationship of current glucocorticoid dose with metabolic outcomes in CAH: analysis of the United Kingdom congenital adrenal hyperplasia adult study executive (CaHASE) cohort

Han T. , Stimson R. , Rees A. , Krone N. , Willis D. , Wild S. , Conway G. , Arlt W. , Walker B. , Ross R. , CaHASE X.

We have previously reported the following metabolic abnormalities were common in 203 adult patients with CAH: obesity (41%), hypercholesterolemia (46%), insulin resistance (29%), osteopenia (40%) and osteoporosis (7%) (Arlt et al. JCEM 2010 95 5110–21). The CAH patients were taking different glucocorticoid therapies at various doses (n=196): hydrocortisone (n=25 M, 26 W), prednisolone (n=21M,67W), dexamethasone (n=15M,22W) or comb...

ea0029p171 | Bone & Osteoporosis | ICEECE2012

Denosumab increases BMD in primary hyperparathyroidism

Misiorowski W. , Zgliczynski W.

Primary hyperparathyroidism (PHPT) is often associated with reduced bone mineral density (BMD). An open-labeled, prospective trial was conducted to determine whether denosumab 60 mg subcutaneously given every 6 months, maintains or improves BMD in patients with PHPT.Six patients had symptomatic PHPT and met surgical guidelines however refused surgery, and twelve patients had mild PHPT, asymptomatic except low BMD. The primary outcome index, BMD, was meas...

ea0063p1046 | Pituitary and Neuroendocrinology 3 | ECE2019

Recovery of the hypothalamic-pituitary-adrenal and gonadal axes following trans-sphenoidal adenomectomy, a single centre experience

Pofi Riccardo , Gunatilake Sonali , Macgregor Victoria , Cudlip Simon , Joseph Robin , Lenzi Andrea , Tomlinson Jeremy W , Jafar-Mohammadi Bahram , Isidori Andrea M , Pal Aparna

Hypopituitarism is a potential complication of trans-sphenoidal adenomectomy (TSA). Prediction of pituitary function (PF) recovery would inform hormonal replacement strategies. However, the frequency of re-testing of PF is variable across centres. The aim of this study was to determine rates, time and predictors of 6-weeks (6 w) recovery of hypothalamo-pituitary adrenal (HPA) and gonadal function after TSA.Methods: We performed a single-centre, retrospec...

ea0026oc3.5 | Bone/Reproduction | ECE2011

IGF1 promotes survival of mast cells and regulates their number in the developing mammary gland

Ameri P , Yozgat Y , Ruan W , Murialdo G , Besmer P , Ferone D , Kleinberg D

We found that mast cells were present in pubertal mammary glands, and hypothesized that they participate in mammary morphogenesis and are sensitive to IGF1, which is essential for mammary development.As independently reported in another model of mast cell deficiency (Developmental Biology 2010 337 124), mast cell-deficient W/Wv mice had significantly less terminal end buds and ducts and smaller gland areas than controls at 3, 6, ...

ea0032s28.1 | Autoimmune endocrine disease - Old and new players | ECE2013

Autoimmune thyroid disease

Wiersinga W

Graves’ hyperthyroidism (GH) and Hashimoto’s hypothyroidism (HH) are the opposite ends of the clinical expression of autoimmune thyroid diseases (AITD). AITD are multifactorial ‘complex’ diseases in which immune responses against thyroid antigens develop in genetic susceptible subjects, provoked by environmental factors. Susceptibility genes include immunoregulatory genes (HLA, CTLA-4, PTPN22, CD4 and FCRL3) and thyroid-specific genes (TSHR and Tg). Environ...